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Background: Shoulder pain affects all ages, with a lifetime prevalence of one in three. The most effective
treatment is not known. Physiotherapy is often recommended as the first choice of treatment. At present, it is not
possible to identify, from the initial physiotherapy assessment, which factors predict the outcome of physiotherapy
for patients with shoulder pain. The primary objective of this study is to identify which patient characteristics and
baseline measures, typically assessed at the first physiotherapy appointment, are related to the functional outcome
of shoulder pain 6 weeks and 6 months after starting physiotherapy treatment.
Methods/Design: Participants with musculoskeletal shoulder pain of any duration will be recruited from
participating physiotherapy departments. For this longitudinal cohort study, the participants care pathway,
including physiotherapy treatment will be therapist determined.
Potential prognostic variables will be collected from participants during their first physiotherapy appointment and
will include demographic details, lifestyle, psychosocial factors, shoulder symptoms, general health, clinical
examination, activity limitations and participation restrictions.
Outcome measures (Shoulder Pain and Disability Index, Quick Disability of the Arm, Shoulder and Hand, and Global
Impression of Change) will be collected by postal self-report questionnaires 6 weeks and 6 months after
commencing physiotherapy.
Details of attendance and treatment will be collected by the treating physiotherapist. Participants will be asked to
complete an exercise dairy.
An initial exploratory analysis will assess the relationship between potential prognostic factors at baseline and
outcome using univariate statistical tests. Those factors significant at the 5% level will be further considered as
prognostic factors using a general linear model.
It is estimated that 780 subjects will provide more than 90% power to detect an effect size of less than 0.25
adjusted for other variables which have a co-efficient of determination (R-squared) with the outcome of up to 0.5.
Assuming a 22% loss to follow up at 6 months, 1000 participants will initially be recruited.
Discussion: This study may offer service users and providers with guidance to help identify whether or not
physiotherapy is likely to be of benefit. Clinicians may have some direction as to what key factors indicate a
patient’s likely response to physiotherapy.
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Shoulder pain is a common and often persistent muscu-
loskeletal problem affecting all ages, with a lifetime
prevalence of one in three [1].
In 2011–2012, the prevalence of work related upper
limb disorders in Great Britain exceeded that of low back
pain [2]. Shoulder pain is one of the most common mus-
culoskeletal disorders in the working population [3]. The
cost of shoulder pain to healthcare and its effect on the
economy is unclear. Both Dutch [4] and Swedish [5] stud-
ies have demonstrated that between 50 [4] and 84 [5] per-
cent of overall costs due to shoulder pain is related to sick
leave. Sickness absence due to shoulder pain in young
working adults has been linked with high levels of sickness
absence due to other diagnoses in subsequent years [6].
In primary care, shoulder pain is the third most common
musculoskeletal presentation [7]. Of those people who
chose to visit their General Practitioner with first episode
shoulder pain, only 50 percent show complete recovery six
months later [8]. At one year follow up, recovery rate in-
creases by only 10 percent [8]. The most effective treat-
ment for musculoskeletal shoulder pain is not yet known.
Conservative management in the form of physiotherapy is
therefore often recommended as the first choice of treat-
ment [9]. Indeed, up to one third of patients referred for
physiotherapy musculoskeletal outpatient services in pri-
mary care have shoulder pain [10]. Although physiotherapy
constitutes a relatively low proportion of the overall cost,
in relation to total healthcare costs, physiotherapy accounts
for between 37 [4] and 60 percent [5].
When physiotherapy is unsuccessful, other interven-
tions such as pain management clinics or surgery are
often considered. However, there is already some evi-
dence that longer duration of shoulder symptoms is as-
sociated with an increased likelihood of chronic pain
[11]. It is therefore important, that wherever possible,
the most appropriate treatment for any individual is
identified early on in the clinical pathway.
At present, it is not possible to identify, from the initial
physiotherapy assessment, which factors predict the out-
come of physiotherapy for patients with shoulder pain. Re-
search has shown that a range of biopsychosocial factors
are related to outcome following surgical [12] or General
Practitioner [11,13-15] management of shoulder pain. This
study aims to identify which factors are related to outcome
of shoulder pain following physiotherapy.
A greater knowledge of prognostic factors in terms of
who is likely to respond to physiotherapy and who will
not is vital for patients, healthcare professionals and
commissioners and ensures effective and efficient use of
limited resources. Additional benefits include:
 Enabling patients to make an informed choice
about whether or not they wish to pursuephysiotherapy based on the prognosis of a positive
outcome.
 Facilitating greater confidence in physiotherapy
treatment, leading to greater compliance and less
non attendance.
 Assisting physiotherapists in terms of effective and
timely decision making and best utilization of
limited resources.
 Providing all health care professionals with a clinical
reasoning tool to help distinguish between patients
who will respond to physiotherapy, and those who
will go on to have persistent symptoms and may
benefit from earlier referral to the multidisciplinary
team for a surgical opinion or chronic pain
management.
 Minimising the negative consequences of chronic
pain and disability, for example associated
depression, time off work, utilisation of health
resources and disablement resettlement [16,17].
Study objectives
The primary objective of this study is to identify which
patient characteristics and baseline measures, commonly
assessed at the first physiotherapy appointment, are re-
lated to the functional outcome of shoulder pain 6 weeks
and 6 months after starting physiotherapy treatment.
The secondary objectives of this study are to:
i. describe a typical programme of physiotherapy for
the management of shoulder pain and
ii. to describe the outcomes of physiotherapy in
relation to physiotherapy treatments.Methods/Design
Study design
A longitudinal cohort study of prognostic factors.
Study setting
Potential participants will be selected from patients re-
ferred for the management of shoulder pain to participat-
ing physiotherapy out-patient musculoskeletal departments
based in General Practice, primary and secondary care
hospital sites in the Eastern Counties of England from
November 2011 to September 2013.
Eligibility criteria
Participants must be 18 years or older, with musculo-
skeletal shoulder pain of any duration, and reproduction
of shoulder pain and/or restriction on active or passive
movement in at least one direction. Participants must
score 8 or more on the Shoulder Pain and Disability Index
(SPADI) [18] or Quick Disability of the Arm, Shoulder
and Hand Questionnaire (QuickDASH) [19].
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ery, participants presenting post operatively, with serious
trauma or pathology to the shoulder, or with pathologies
or syndromes which refer directly to the shoulder are
excluded.
Exclusion criteria
 Fracture of the affected shoulder in the last five
years.
 Dislocation of the affected shoulder which has
resulted in a visit to secondary care and investigative
radiology in the last five years.
 Surgical intervention on the affected shoulder in the
last five years. (This does not include
hydrodilatation, manipulation under anaesthetic or
local steroid injection).
 Systemic condition with significant musculoskeletal
component (i.e. inflammatory joint disease,
polymyalgia rheumatica, neoplastic disorder).
 Complex regional pain syndrome.
 Predominant reproduction of shoulder pain on
movements of the cervical or thoracic spine rather
than shoulder movement.
 Neck pain related to serious pathology, myelopathy
or radiculopathy.
 Known neoplasm.
Care pathways and physiotherapy
The clinical pathway for patients recruited onto this ob-
servational study remains the same; physiotherapy treat-
ment, referral pathways and waiting times are unaffected.
Physiotherapy usually includes advice and exercise but
may also include additional pain neuromodulatory tech-
niques such as manual therapy or electrotherapy. The
Chartered Society of Physiotherapy have developed evi-
dence based guidelines for the management of some
clinical presentations of shoulder pain [20,21]. Shoulder
exercises have been demonstrated and recommended as
an effective form of physiotherapy [20-23]. However as yet
there is no evidence that one form of shoulder exercise
is superior to another [22,23]. Physiotherapy guidelines
and reviews generally recommend passive pain modula-
tory treatments as adjuncts to exercise rather than stand
alone treatments [20,21,23-25]. With the exception of
exercise, there is currently no convincing evidence that
any one type of physiotherapy treatment is superior to
another [9,23].
Prognostic factors
The International Classification of Functioning, Disability,
and Health [26] highlight the importance of an integrative
approach to patient assessment in which impairment,
activity, and participation are considered. The potential
prognostic factors recorded at the initial physiotherapyappointment for this study will reflect this. Potential prog-
nostic variables will include:
 Demographic details.
 Individual participant characteristics.
 Lifestyle, psychosocial factors, past experience and
expectations of physiotherapy.
 Shoulder symptoms and general health.
 Signs of impairment from the objective/clinical
examination.
 Activity limitations and participation restrictions.Outcome measures
The primary outcome measure is the Shoulder Pain and
Disability Index (SPADI) [18,27]. This region specific self
report questionnaire is designed to measure pain and
disability associated with shoulder pain of musculoskel-
etal or undetermined origin. Thirteen items, covering
two domains (pain and disability) are scored on a nu-
merical rating scale between zero (no pain/difficulty)
and ten (worst pain imaginable/so difficult it requires
help). Each domain carries equal weighting in the overall
score which is expressed as a percentage where zero repre-
sents no pain or disability and 100% represents maximum
pain and disability. Previous research has demonstrated no
floor and no or very low ceiling effects, excellent reliability
[28], responsiveness [29] and ability to discriminate be-
tween different severities of shoulder pain [30].
The secondary outcome of the study is the Quick
Disability of the Arm, Shoulder and Hand Questionnaire
(QuickDASH) [31]. The QuickDASH is a broader region
specific patient rated questionnaire. Eleven items, cover-
ing six domains (daily activities, symptoms, social func-
tion, work function, sleep, and confidence) are scored on
a numerical rating scale between one (no difficulty) and
five (unable). The overall score is expressed as a percentage
where zero represents no disability and 100% represents
maximum disability. Previous research has demonstrated
good responsiveness [31,32] and similar validity, reliability
and precision to the Disability of the Arm, Shoulder and
Hand Questionnaire [33].Sample size
A formal sample size calculation is difficult given the
lack of published information on correlations between
putative prognostic factors and outcome. However, using
the approach suggested by Lipsitz and Parzen [34] 780
subjects would provide more than 90% power to detect
an effect size of less than 0.25 adjusted for other vari-
ables which have a co-efficient of determination (R-
squared) with the outcome of up to 0.5. Assuming a 22%
loss to follow up at 6 months, 1000 participants will ini-
tially be recruited.
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the period March 2009–2010 indicated that 1500 poten-
tial participants with shoulder pain were referred over a
12 month period. However changes in working practice
and referral patterns, and the addition of more exclu-
sion criteria indicate that further sites will be required
to meet this target. Additional NHS healthcare trusts/
social enterprises, some of which include a number of
potential locations, have therefore been included as po-
tential sites with some of these contingency sites. Rates
of recruitment and completion rates at 6/52 and 6/12
will be monitored each month and additional sites
recruited as indicated.
Participant selection and recruitment
Potential participants will be identified at each site from
the letter of referral. At a similar time to the first physio-
therapy appointment being posted to the patient, a sep-
arate envelope containing an invitation pack will be sent
to all potential participants. See Figure 1 for an outline
of the patient pathway. The invitation pack, previously
prepared, stamped and signed by the Chief Investigator
will be non-personalised and will contain a Patient Infor-
mation Sheet. This will clearly state that involvement in
the study is voluntary and that participants will be free
to withdraw from the study at any time. It will alsoChief 
Investigator CI Participants
Patients referred to Physiotherapy with shoulder pain
Potential 
participants 
contact CI with 
any quesitons 
about the study
Potential participants receive invitation to the study.
Interested potential participants self assess eligability using 
screening questionnaire
Non eligible patients: Standard clinical pathway. No further ac
Eligable patients
1. Self consent using enclosed consent form
2. Completebooklet of questions
Participant attends first physiotherapy appointment and
1. Gives physiotherapist their signed consent form and rece
a copy back
2. Gives booklet of questions to PT in sealed envelope
3. Receives normal physiotherapy assessment
Sends 
questionnaire to 
participants at 6 
weeks and 6 
months and 
receives replies
Postal quesitonnaire 
at 6 weeks.
Receives, completes 
and returns with 
exercise diary to CI
Keeps 
simple 
diary of 
exercise 
adherence
Receives 
physiotherapy 
treatment whic
unaffected by t
study
Postal quesitonnaire 
at 6 months (as 6 
weeks)
Figure 1 Patient pathway with reference to physiotherapy and the chinclude contact details of the Chief Investigator to pro-
vide the opportunity for further questions. A variety of
contact methods will be provided; e-mail, study mobile
number, landline with 24 hour answer machine and
postal address.
A self screening questionnaire, key questions of which
are presented in Additional file 1, will be provided
within the invitation pack. If the patient wishes to take
part in the study they will be asked to complete the
screening questionnaire at home prior to their first
physiotherapy appointment.
Informed self consent
If the patient appears eligible upon self screening and
wishes to take part in the study they will also be asked
to complete the consent form enclosed within the invitation
pack. On arriving for their first physiotherapy appointment,
potential participants who fulfill the eligibility criteria via
the screening questionnaire and provide written informed
consent will be enrolled onto the study. The physiotherapist
treating the participant will check the screening and con-
sent forms have been accurately completed.
The lead physiotherapist at each site will be asked to keep
a log of the number of patients who are eligible and con-
sent versus those who are eligible and do not consent. In
addition the age, sex and index of social deprivation of allPhysiotherapist(s) Chief 
Investigator
Identifies potential participants from letter of 
referral
tion.
Sends pre-prepared envelopes to potential 
participants containing
1. Invitation to the study/patient info sheet
2. Screening questionnaire
3. Enclosed envelope containing
a. Consent form
b. Booklet of quesitons
ives 1. Checks, signs and copies consent form
2. Forwards to CI
3. Records subjective and objective 
assessment including some additional 
tests on standardised forms
Receives 
copies
h is 
he 
Records treatment on standardised form and 
sends copy to CI
Receives 
copy
ief investigator.
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allow comparisons between consenters and non consenters.
Collection of baseline prognostic factors
Predetermined factors, which may predict outcome from
physiotherapy will be measured and collected prior to
and during the first physiotherapy appointment via three
methods; the participant will complete a “booklet of
questions” provided within their patient invitation pack
and their physiotherapist will record selected details of
their initial subjective and clinical assessment on a clin-
ical record form.
Demographic and individual participant characteristics
including activity and participation
Data about demographics and individual characteristics
will be collected via an eight page A4 sized “booklet of
questions” which will be completed by the patient at home
prior to their first physiotherapy appointment. This con-
tains individual questions about the participant and the
characteristics of their shoulder pain, their work, everyday
activities, and lifestyle, their experience of physiotherapy
in the past, motivational factors and expectations of
physiotherapy for their current shoulder symptoms. In
addition the booklet contains four validated self report
questionnaires. These have been selected based on their
psychometric properties in similar populations and re-
spondent burden. The Pain Self Efficacy Scale [35] re-
quires the participant to state their confidence, despite
their pain, on a scale of 0–6 in 10 domains. The total
score ranges from 0–60 where a higher score represents
greater self efficacy beliefs. The “Godin leisure time exer-
cise questionnaire” [36-38] requires participants to state
how often they perform mild, moderate and strenuos ex-
ercise per week and how often they “work up a sweat”.
The results are used to calculate weekly metabolic equiva-
lents (METs). Pain, symptoms and disability will be mea-
sured using the SPADI [18] and QuickDASH [31]. The
participant will also be asked to estimate their expected
recovery on a seven point global impression of change.
Due to the sensitive nature of some of the topics partici-
pants will be asked to place the “booklet of questions” in a
sealed envelope before giving it to their physiotherapist at
their first appointment.
Shoulder symptoms and general health
Details about shoulder symptoms and general health will
be collected and recorded in part by the participant
within the “booklet of questions” and in part by the
physiotherapist during the subjective assessment. Phys-
iotherapists will record details of co-morbidities, work
status and the distribution, cause, onset and duration of
the participant’s current shoulder symptoms on a clinical
record form specifically designed for this study.Signs of impairment from the objective/clinical examination
Signs of impairment will be measured and recorded by the
participant’s physiotherapist during the objective/physical
examination on the clinical record form. This will include
the following: the effect of spinal movement on shoulder
pain, the range and limiting factor for active and passive
flexion, abduction and external rotation of the shoulder,
myometry readings for painfree isometric abduction and
external rotation, response to manual facilitation of the
scapula during shoulder elevation, and the physiothera-
pist’s assessment of the clinical problem. Finally, based on
their assessment, physiotherapists will provide an estimate
of the participant’s predicted recovery during the course of
physiotherapy on a seven point global impression of
change. All participating physiotherapy departments will
receive a formal site initiation visit by the Chief Investiga-
tor during which training on standard operating proce-
dures for data collection will take place. Physiotherapists
will be also be provided with written definitions and quick
reference illustrations of standardised operating proce-
dures for each clinical examination used in the study.Collection of outcome measures
Outcome measures (SPADI, QuickDASH and Global
Impression of Change) will be collected by postal self re-
port questionnaires 6 weeks and 6 months after com-
mencing physiotherapy. The participant will not have
access to the responses they provided to these same
questions at baseline or at previous follow ups. The chief
investigator will be blinded to previous data entries
when inputting data from the 6 week and 6 month
follow up questionnaires. To maximise response rates,
non-responders will be sent two text messages, e-mails
or postal reminders to return their questionnaires. The
“Booklet of Questions” filled in prior to the first physio-
therapy appointment will ask each participant which of
these methods the participant prefers.Collection of details of physiotherapy treatment,
attendance and exercise adherence
Physiotherapists will record details of treatment and the
participant’s attendance/non attendance, on a customised
clinical record form specifically designed for this study.
This will be completed and then returned to the Chief in-
vestigator when the participant is discharged from physio-
therapy. Participants will record exercise adherence for
the first six weeks after their initial physiotherapy appoint-
ment using a simple diary specifically designed for the
study and provided by the physiotherapist at their initial
assessment. This will be returned to the Chief Investigator
with the 6 week follow up questionnaire. Specific details
of exercise adherence over the longer term will be re-
quested within the 6 month follow up questionnaire.
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physiotherapy
Details of any treatments received in addition to that
provided by the participant’s NHS physiotherapist (in-
cluding increase in pain medication) will be requested
within the 6 week and 6 month follow up questionnaire.
Adverse events
It is not expected that any adverse events will occur as a
result of this observational study. However Principal In-
vestigators at each site will be asked to record and notify
the Chief Investigator should any occur. Information
about participants who worsen with physiotherapy will
be captured at 6 week and 6 month follow up.
Data management
Data collected at each site will be sent to the Chief Investi-
gator via internal post or via registered courier. Data will
then be transferred using a Microsoft access data base,
onto a password protected file store. Handling of all per-
sonal data from patients who have consented to be in the
study will be done in compliance with the Data Protection
Act [39]. The dataset held will be pseudoanonymised
meaning that a unique identifier will be used to link pa-
tients’ data to their personal details. Personal details are
required by the Chief Investigator to send questionnaires
to participants’ home addresses at 6 week and 6 month
follow up.
Data values will be electronically range checked during
entry onto the access database. Unusual or unexpected
clinical findings at baseline will be discussed with the
participant’s physiotherapist for further clarity. Physio-
therapists and participant’s will be contacted for missing
data. All anonymised data entries will be double checked
for accuracy and any amendments recorded.
Anonymised data will be transferred to STATA
(Timberlake UK) for statistical analysis.
Statistical analysis
An initial exploratory analysis will be used to assess the
relationship between potential prognostic factors at base-
line and outcomes at the two follow-up time points using
univariate statistical tests. Those factors that are signifi-
cant at the 5% level will be further considered as prognos-
tic factors using a general linear model. A stepwise
selection process, based on change in scaled deviance, will
be used for model construction. Residuals will be exam-
ined to assess the assumption of a Normal distribution. In
the case that a Normal distribution cannot be assumed,
transformations, such as a logarithmic transformation will
be used. Sensitivity analyses will be carried out by remov-
ing extreme and influential observations and assessing
changes on the estimates of the model parameters.Data on physiotherapy treatment will be presented in
a descriptive manner. An exploratory analysis of the po-
tential correlation between treatment variables and out-
come will be conducted although the former will not be
considered as prognostic factors as they are clearly not
available to patients or health professionals prior to the
commencement of physiotherapy.
Baseline measurements will be compared between par-
ticipants who complete and those who do not complete
data collection at 6 week and 6 month follow up periods
to assess the potential to bias the results.
Patient and public involvement
The preliminary work undertaken for this proposal has
been in collaboration with the local Public and Patient In-
volvement in Research (PPIRes) project who are linked to
INVOLVE, the national advisory group, funded by the Na-
tional Institute for Health Research (NIHR). The group
has provided feedback on previous draft proposals on re-
search for Physiotherapy and shoulder pain and agreed
that this was an important area for research. Recruitment
and procedural suggestions from the consumers’ perspec-
tive were offered during the development of the protocol.
The project steering group includes two members of
PPIRes who will provide on-going feedback on revisions
of participant documentation and suggestions to maximise
participant recruitment. PPIRes members of the steering
group will play a key role in dissemination of the results
to the public.
Service provider involvement
Principal Investigators whose sites would definitely be
involved in recruiting participants attended two four
hour workshops at the University of East Anglia in April
2011 and October 2011. The initial workshop focused
on procedural details, in particular upon reaching a con-
sensus of which prognostic factors it would be feasible
to collect, by whom and by what methods and measure-
ments. This necessitated achieving a balance between
the limited evidence base, expert opinion and operator
burden (physiotherapist and potential participant). The
group also discussed recruitment and consenting proce-
dures and methods for recording treatment. The second
workshop focused upon good clinical practice require-
ments and applications to the study, the content of site
initiation visits, and problem solving for potential re-
cruitment and consenting issues.
Discussion
Shoulder pain affects basic activities of daily living such
as toileting and dressing, many recreational and sporting
activities and is one of the most common musculoskel-
etal conditions in the working population. A lack of ap-
propriate and timely intervention can lead to social
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absence and worklessness. This obviously has an impact
on the prosperity and economic recovery of any nation.
Increasingly demands on health services for an ever-
growing population mean that difficult choices are being
made in terms of where resources are best allocated for
an effective quality service. Quality care demands that
treatment provided is tailored to provide the most effect-
ive care pathway for any given individual.
Everyday decisions made by clinicians have an impact
on the quality of care provided and experienced by pa-
tients [40]. Prompt selection of the appropriate clinical
pathway for individuals with musculoskeletal shoulder
pain is essential – some but not all patients with shoul-
der pain will respond to physiotherapy. Inappropriate re-
ferral down a less effective route and/or delayed referral
to more appropriate care are more likely to lead to long-
term chronic or persistent pain. Chronic pain is less
likely to respond to treatment. In addition to the per-
sonal burden for the individual, continued referral from
one department to another is a costly, ineffective, and
inefficient use of health resources.
This study will provide service users and providers
with some of the information necessary to identify
whether or not physiotherapy is likely to be of benefit.
For the first time clinicians will have some guidance as
to what key factors indicate a patients likely response to
physiotherapy. Physiotherapy is a relatively safe, non-
invasive, and for many, an effective intervention. This
valuable resource can therefore be utilized to maximum
effect. Individuals who are unlikely to respond to physio-
therapy can be promptly referred to other services so in-
creasing the likelihood of their success.
This study will provide a basis for future research to
develop and validate a clinical prediction rule for physio-
therapy and shoulder pain. It will also help to describe
what constitutes “standard physiotherapy” for musculo-
skeletal shoulder pain in England, and allow a more
rigorous justification of the “control” arm of physiother-
apy when comparing the effectiveness of other physio-
therapy treatments or treatments other than standard
physiotherapy.
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